ROCKET PHARMACEUTICALS, INC. (RCKT) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-07-07

ROCKET PHARMACEUTICALS, INC. (RCKT) has filed 15 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-07. 5 Form 8-K material event filings were reported by RCKT in the last 90 days. 9 Form 144 notices of proposed sale were filed for RCKT stock. InsiderAlpha tracks every RCKT SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About ROCKET PHARMACEUTICALS, INC. (RCKT)

SIC classificationPharmaceutical Preparations (SIC 2834)
SEC CIK0001281895

90-Day SEC Filing Activity

Form 4 filings (90d)15
Form 8-K filings (90d)5
Form 144 notices (90d)9
Latest Form 4 filing2026-07-07

Recent RCKT Insider Transactions (Form 4)

DateInsiderRoleTransactionSharesPriceValueFiling
WONG RODERICKInsiderA — Grant or award27.8K$0.00—SEC
Dolsten MikaelInsiderA — Grant or award22.9K$0.00—SEC
Malik Fady IbrahamInsiderA — Grant or award22.9K$0.00—SEC
Fong PeterInsiderA — Grant or award22.9K$0.00—SEC
BOESS CARSTENInsiderA — Grant or award22.9K$0.00—SEC
SOUTHWELL DAVID PInsiderA — Grant or award22.9K$0.00—SEC
Shah GauravCEOM — Option exercise76.5K$1.69$129KSEC
Shah GauravCEOS — Open-market sale55.7K$3.09$172KSEC
Wilson MartinGeneral CounselS — Open-market sale662$3.01$2KSEC
Shah GauravCEOS — Open-market sale2.4K$3.01$7KSEC
Militello JohnSee RemarksS — Open-market sale384$3.01$1KSEC
Wilson MartinGeneral CounselS — Open-market sale3.4K$3.61$12KSEC
Militello JohnSee RemarksS — Open-market sale855$3.61$3KSEC
Shah GauravCEOS — Open-market sale2.7K$3.61$10KSEC
Chaudhuri SarbaniSee RemarksS — Open-market sale17.6K$3.84$68KSEC

All transactions sourced from SEC EDGAR Form 4 filings for ROCKET PHARMACEUTICALS, INC. (RCKT). Updated in real time as new filings are submitted to the SEC.

Most-Active RCKT Insiders — Last 90 Days

InsiderForm 4 filingsTotal transaction value
Militello John19$4K
Shah Gaurav5$448K
SOUTHWELL DAVID P2—
BOESS CARSTEN2—
Dolsten Mikael2—

Recent RCKT Form 8-K Material Events

Recent RCKT Form 144 Notices of Proposed Sale

Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.

Recent Insider Filings

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in RCKT insider filings:

POpen-market purchase by the insider
SOpen-market sale by the insider
AGrant, award, or other acquisition from the issuer
MExercise or conversion of derivative security (e.g. options)
FPayment of exercise price or tax liability via share withholding
GBona-fide gift of securities
DDisposition to the issuer (e.g. share buyback participation)
JOther acquisition or disposition
XExercise of in-the-money or at-the-money derivative security
CConversion of derivative security
VTransaction voluntarily reported earlier than required

RCKT Insider Trading — FAQ

What is the latest insider trade for RCKT?
ROCKET PHARMACEUTICALS, INC. (RCKT) had 15 insider filings in the last 90 days, with the most recent on 2026-07-07. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying RCKT stock?
0 insider purchases of RCKT were filed in the last 90 days.
How many insiders are selling RCKT stock?
0 insider sales of RCKT were filed in the last 90 days.
Where can I see RCKT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
InsiderAlpha aggregates every RCKT SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Related Companies — Recent Insider Activity

Learn More

Open the live RCKT dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.